Loading...
Market
How many countries will adopt similar mRNA cancer vaccines by the end of 2025?
2
Resolution / Starting Odds
No countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
Announcements from health ministries of other countries or major news outlets
Story
Russia to Launch Free mRNA Cancer Vaccine for Patients in Early 2025, Costs 300,000 Rubles per Dose
Dec 18, 2024, 11:23 AM
Russia has announced the development of a new mRNA-based cancer vaccine, which is set to be distributed free of charge to patients starting in early 2025. The vaccine, designed to treat cancer rather than prevent it, will be personalized for each patient, utilizing genetic material from their own tumors. According to Andrey Kaprin, the chief oncologist at the Ministry of Health, the vaccine will cost the state approximately 300,000 rubles per dose. This initiative aims to make advanced cancer treatment accessible to all Russian citizens, marking a significant advancement in the country's healthcare offerings.
View original story
Similar markets
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Less than 20 countries • 25%
20 to 40 countries • 25%
41 to 60 countries • 25%
More than 60 countries • 25%
0-2 countries • 25%
3-5 countries • 25%
6-8 countries • 25%
9 or more countries • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
None • 25%
Europe • 25%
Asia • 25%
Both Europe and Asia • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
China • 25%
India • 25%
Brazil • 25%
Other • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%